Table 1 Baseline characteristics for 219 patients managed with 287 treatment courses. Information is displayed for individual treatment courses

Female sex

118

41

Male sex

169

59

Age ≤ 70 years

154

54

Age 71–80 years

94

33

Age ≥ 81 years

39

14

Prostate cancer

72

25

Non-small cell lung cancer

56

20

Breast cancer

53

19

Small cell lung cancer

11

4

Renal cell cancer

17

6

Colorectal cancer

32

11

Bladder cancer

10

4

Other primary tumors

36

12

KPS < 50*

22

8

KPS 50–70*

153

53

KPS 80–100*

112

39

Outpatient**

182

63

Inpatient**

105

37

One or two target volumes irradiated

206

72

Three or more target volumes irradiated

81

28

Osseous metastases irradiated (exclusively)

234

82

Extraosseous metastases irradiated

53

18

Pain indication for RT

245

85

Non-pain indication (neurological etc.)

42

15

Prescribed regimen of 10 fractions

100

35

Prescribed regimen of 1 fraction

70

24

Prescribed regimen of 2–5 fractions

117

41

Incomplete radiotherapy

9

3

No systemic therapy

64

22

Ongoing systemic therapy within last 4 weeks

180

63

Systemic therapy > 4 weeks before RT

43

15

Systemic chemotherapy

99

34

Endocrine treatment

101

35

Immune checkpoint inhibitor

9

3

Tyrosine kinase inhibitor

14

5

Corticosteroid concomitant to RT

115

40

No corticosteroid concomitant to RT

172

60

Opioid analgesic concomitant to RT

189

66

No opioid analgesic concomitant to RT

98

34

Palliative care team involved**

96

33

Palliative care team not involved**

191

67

Early RT, within 2 mo from cancer diagnosis

91

32

Late RT, > 2 months

196

68

Low hemoglobin*

174

61

Normal hemoglobin*

112

39

Hypercalcemia*

18

6

Normal calcium*

262

91

Low albumin*

41

14

Normal albumin*

229

80

High lactate dehydrogenase*

116

40

Normal lactate dehydrogenase*

122

43

High alkaline phosphatase*

157

55

Normal alkaline phosphatase*

111

39

Leukocytosis*

54

19

Leukopenia*

13

5

Normal leukocytes*

219

76

High C-reactive protein > 90 mg/L*

39

14

High C-reactive protein < 90 mg/L*

159

55

Normal C-reactive protein*

84

29

Abnormal platelet count*

56

20

Normal platelet count*

229

80

Low creatinine*

61

21

Normal creatinine*

194

68

High creatinine*

32

11

Brain metastases

25

9

Liver metastases

87

30

Lung metastases

93

32

Adrenal gland metastases

23

8

Pleural effusion***

27

9

Disease progression in non-irradiated area

132

46

Stable disease outside irradiated area

152

53

Weight loss of at least 10% (last 6 mo)

98

34